viral inactivation market

1
MarketsandMarkets Presents
Viral Inactivation Market worth 573.0 Million USD
by 2021
http//www.marketsandmarkets.com/Market-Reports/vi
ral-inactivation-market-121427017.html
2
The report "Viral Inactivation Market by Product
(Kits, Reagents, Systems, Services), Application
(Stem Cell, Blood, Tissue, Cell Gene Therapy),
Method (Solvent Detergent, Pasteurization) End
User (Pharmaceutical and Biotechnology, CROs) -
Global Forecast to 2021"The global viral
inactivation market was valued at USD 320.5
Million in 2016. This market is expected to grow
at a CAGR of 12.3 to reach USD 573.0 Million in
2021. Browse 72 market data tables with 70
figures spread through 154 pages and in-depth TOC
on "Viral Inactivation Market http//www.marketsa
ndmarkets.com/Market-Reports/viral-inactivation-ma
rket-121427017.html Early buyers will receive 10
customization on This report. Viral inactivation
testing is necessary by regulatory authorities
for investigational new drug (IND) submission and
is mainly critical in process development for
biologicals including tissue and tissue products,
stem cell products, cellular and gene therapy
products, blood and blood products, and vaccine
and therapeutics.
http//www.marketsandmarkets.com/Market-Reports/vi
ral-inactivation-market-121427017.html
3
The major drivers for the market are rapid growth
in pharmaceutical and biotechnology industries
and strong trend of RD investments in life
sciences industry. Increasing number of new drug
launches, rise in chronic disease burden, and
increasing government support for the
pharmaceutical and biotechnology industries will
also aid the growth of this market. The global
viral inactivation market is segmented on the
basis of method, product, application, end user,
and geography. By method, the market is divided
into solvent detergent method, pasteurization,
and other methods. Other viral inactivation
method includes low pH, microwave heating,
irradiation, and high-energy light. Of these, the
solvent detergent method segment accounted for
the largest share of the global viral
inactivation market in 2015. The application
segments included in this report are blood
blood products, cellular gene therapy products,
stem cell products, tissue tissue products, and
vaccines and therapeutics. Of these the vaccines
and therapeutics application hold the highest
share.
http//www.marketsandmarkets.com/Market-Reports/vi
ral-inactivation-market-121427017.html
4
The product segments included in the report are
kits and reagents, services, and viral
inactivation systems and accessories. The Sample
Report For This Report_at_ http//www.marketsandmark
ets.com/requestsample.asp?id121427017 By end
user, the market is segmented into pharmaceutical
and biotechnology companies, contract research
organizations, academic research institutes, and
other end users. Other end user segment primarily
includes cell banks, small cell culture
laboratories and consultants, microbiology
laboratories, immunology laboratories, molecular
laboratories, animal facilities, toxicology
laboratories, and media/sera manufacturers.
http//www.marketsandmarkets.com/Market-Reports/vi
ral-inactivation-market-121427017.html
5
The geographic segments included in this report
are Asia, Europe, North America, and the Rest of
the World (RoW). The North America segment is
further divided into Canada and the U.S. Asia
segment is further divided into China, Japan,
India, and Rest of Asia. Get The PDF Brochure
For This Report_at_ http//www.marketsandmarkets.com/
pdfdownload.asp?id121427017 Major players in
the viral inactivation market include Clean Cells
(France), Charles River Laboratories
International, Inc. (U.S.), Danaher Corporation
(U.S.), Merck KGaA (Germany), Parker Hannifin
(U.S.), Rad Source Technologies (U.S.), Sartorius
AG (Germany), SGS S.A. (Switzerland), Texcell,
Inc. (France), Viral Inactivated Plasma Systems
SA (Switzerland), and WuXi PharmaTech (Cayman)
Inc. (China).
http//www.marketsandmarkets.com/Market-Reports/vi
ral-inactivation-market-121427017.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/vi
ral-inactivation-market-121427017.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel [phone] Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets